pHTN HaloTag CMV-neo

Mammalian expression vector with a traditional MCS and ampicillin and G418 resistance markers, encoding a cleavable N-terminal HaloTag®.

Sequence Author: Promega

|Download SnapGene Viewer
Explore Over 2.7k Plasmids: Mammalian Expression Vectors | More Plasmid Sets
No matches
BglII (6138) MluI (6019) BspEI (5806) PciI (5042) AgeI (4974) AhdI (4872) XmnI (4272) BamHI (3840) poly(A) signal BstXI (3767) RsrII (3562) NaeI (3548) NgoMIV (3546) PluTI (3049) BsrGI (96) SpeI (152) CMV enhancer NdeI (387) T7 promoter NheI (1052) BmtI (1056) PflMI (1108) AleI (1166) BstEII (1184) BmgBI (1318) PasI (1348) BclI * (1548) PshAI (1613) SgrAI (1700) TspMI - XmaI (1870) SmaI (1872) SalI (1936) AccI (1937) PaeR7I - XhoI (1943) TEV site AsiSI - PvuI (2001) EcoRI (2009) Eco53kI (2018) SacI (2020) SacII (2027) EcoRV (2031) XbaI (2033) PspOMI (2042) ApaI (2046) SbfI (2057) NotI (2066) BlpI (2097) PsiI (2245) HpaI (2265) MfeI (2274) Acc65I (2502) KpnI (2506) CsiI - SexAI * (2619) SV40 promoter SfiI (2805) AvrII (2852) KasI (3045) NarI (3046) SfoI (3047) pHTN HaloTag® CMV-neo 6143 bp
BglII  (6138)
1 site
A G A T C T T C T A G A
MluI  (6019)
1 site
A C G C G T T G C G C A
BspEI  (5806)
1 site
T C C G G A A G G C C T
PciI  (5042)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
AgeI  (4974)
1 site
A C C G G T T G G C C A
AhdI  (4872)
1 site
G A C N N N N N G T C C T G N N N N N C A G

The 1-base overhangs produced by AhdI may be hard to ligate.
Sticky ends from different AhdI sites may not be compatible.
XmnI  (4272)
1 site
G A A N N N N T T C C T T N N N N A A G
BamHI  (3840)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF® (but not the original BamHI) can remain bound to DNA and alter its electrophoretic mobility.
BstXI  (3767)
1 site
C C A N N N N N N T G G G G T N N N N N N A C C

Sticky ends from different BstXI sites may not be compatible.
RsrII  (3562)
1 site
C G G W C C G G C C W G G C

Efficient cleavage requires at least two copies of the RsrII recognition sequence.
Sticky ends from different RsrII sites may not be compatible.
For full activity, add fresh DTT.
NaeI  (3548)
1 site
G C C G G C C G G C C G

Efficient cleavage requires at least two copies of the NaeI recognition sequence.
NgoMIV  (3546)
1 site
G C C G G C C G G C C G

Efficient cleavage requires at least two copies of the NgoMIV recognition sequence.
PluTI  (3049)
1 site
G G C G C C C C G C G G

Efficient cleavage requires at least two copies of the PluTI recognition sequence.
BsrGI  (96)
1 site
T G T A C A A C A T G T

BsrGI is typically used at 37°C, but is even more active at 60°C.
SpeI  (152)
1 site
A C T A G T T G A T C A
NdeI  (387)
1 site
C A T A T G G T A T A C

Prolonged incubation with NdeI may lead to removal of additional nucleotides.
NheI  (1052)
1 site
G C T A G C C G A T C G
BmtI  (1056)
1 site
G C T A G C C G A T C G
PflMI  (1108)
1 site
C C A N N N N N T G G G G T N N N N N A C C

Sticky ends from different PflMI sites may not be compatible.
AleI  (1166)
1 site
C A C N N N N G T G G T G N N N N C A C
BstEII  (1184)
1 site
G G T N A C C C C A N T G G

Sticky ends from different BstEII sites may not be compatible.
BstEII is typically used at 60°C, but is 50% active at 37°C.
BmgBI  (1318)
1 site
C A C G T C G T G C A G

This recognition sequence is asymmetric, so ligating blunt ends generated by BmgBI will not always regenerate a BmgBI site.
PasI  (1348)
1 site
C C C W G G G G G G W C C C

Sticky ends from different PasI sites may not be compatible.
BclI  (1548)
1 site
T G A T C A A C T A G T
* Blocked by Dam methylation.
BclI is typically used at 50-55°C, but is 50% active at 37°C.
PshAI  (1613)
1 site
G A C N N N N G T C C T G N N N N C A G

PshAI quickly loses activity at 37°C, but can be used at 25°C for long incubations.
SgrAI  (1700)
1 site
C R C C G G Y G G Y G G C C R C

Efficient cleavage requires at least two copies of the SgrAI recognition sequence.
TspMI  (1870)
1 site
C C C G G G G G G C C C
XmaI  (1870)
1 site
C C C G G G G G G C C C

Cleavage may be enhanced when more than one copy of the XmaI recognition sequence is present.
SmaI  (1872)
1 site
C C C G G G G G G C C C

SmaI can be used at 37°C for brief incubations.
SalI  (1936)
1 site
G T C G A C C A G C T G
AccI  (1937)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the recognition sequence.
Sticky ends from different AccI sites may not be compatible.
PaeR7I  (1943)
1 site
C T C G A G G A G C T C

PaeR7I does not recognize the sequence CTCTCGAG.
XhoI  (1943)
1 site
C T C G A G G A G C T C
AsiSI  (2001)
1 site
G C G A T C G C C G C T A G C G
PvuI  (2001)
1 site
C G A T C G G C T A G C
EcoRI  (2009)
1 site
G A A T T C C T T A A G
Eco53kI  (2018)
1 site
G A G C T C C T C G A G
SacI  (2020)
1 site
G A G C T C C T C G A G
SacII  (2027)
1 site
C C G C G G G G C G C C

Efficient cleavage requires at least two copies of the SacII recognition sequence.
EcoRV  (2031)
1 site
G A T A T C C T A T A G

EcoRV is reportedly more prone than its isoschizomer Eco32I to delete a base after cleavage.
XbaI  (2033)
1 site
T C T A G A A G A T C T
PspOMI  (2042)
1 site
G G G C C C C C C G G G
ApaI  (2046)
1 site
G G G C C C C C C G G G

ApaI can be used between 25°C and 37°C.
SbfI  (2057)
1 site
C C T G C A G G G G A C G T C C
NotI  (2066)
1 site
G C G G C C G C C G C C G G C G
BlpI  (2097)
1 site
G C T N A G C C G A N T C G

Sticky ends from different BlpI sites may not be compatible.
PsiI  (2245)
1 site
T T A T A A A A T A T T
HpaI  (2265)
1 site
G T T A A C C A A T T G
MfeI  (2274)
1 site
C A A T T G G T T A A C
Acc65I  (2502)
1 site
G G T A C C C C A T G G
KpnI  (2506)
1 site
G G T A C C C C A T G G
CsiI  (2619)
1 site
A C C W G G T T G G W C C A

Sticky ends from different CsiI sites may not be compatible.
SexAI  (2619)
1 site
A C C W G G T T G G W C C A
* Blocked by Dcm methylation.
Sticky ends from different SexAI sites may not be compatible.
SfiI  (2805)
1 site
G G C C N N N N N G G C C C C G G N N N N N C C G G

Efficient cleavage requires at least two copies of the SfiI recognition sequence.
Sticky ends from different SfiI sites may not be compatible.
AvrII  (2852)
1 site
C C T A G G G G A T C C
KasI  (3045)
1 site
G G C G C C C C G C G G
NarI  (3046)
1 site
G G C G C C C C G C G G

Efficient cleavage requires at least two copies of the NarI recognition sequence.
SfoI  (3047)
1 site
G G C G C C C C G C G G
HaloTag®
1067 .. 1957  =  891 bp
297 amino acids  =  33.6 kDa
Product: modified bacterial dehalogenase that forms covalent bonds with chloroalkane derivatives
HaloTag®
1067 .. 1957  =  891 bp
297 amino acids  =  33.6 kDa
Product: modified bacterial dehalogenase that forms covalent bonds with chloroalkane derivatives
TEV site
1970 .. 1990  =  21 bp
7 amino acids  =  900.9 Da
Product: tobacco etch virus (TEV) protease recognition and cleavage site
TEV site
1970 .. 1990  =  21 bp
7 amino acids  =  900.9 Da
Product: tobacco etch virus (TEV) protease recognition and cleavage site
AmpR
4085 .. 4945  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
   Segment 1:  signal sequence  
   4085 .. 4153  =  69 bp
   23 amino acids  =  2.6 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
4085 .. 4945  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
   Segment 2:  
   4154 .. 4945  =  792 bp
   263 amino acids  =  28.9 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
4085 .. 4945  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
NeoR/KanR
2918 .. 3712  =  795 bp
264 amino acids  =  29.0 kDa
Product: aminoglycoside phosphotransferase from Tn5
confers resistance to neomycin, kanamycin, and G418 (Geneticin®)
NeoR/KanR
2918 .. 3712  =  795 bp
264 amino acids  =  29.0 kDa
Product: aminoglycoside phosphotransferase from Tn5
confers resistance to neomycin, kanamycin, and G418 (Geneticin®)
ori
5103 .. 5691  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
ori
5103 .. 5691  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
CMV enhancer
138 .. 517  =  380 bp
human cytomegalovirus immediate early enhancer
CMV enhancer
138 .. 517  =  380 bp
human cytomegalovirus immediate early enhancer
SV40 promoter
2510 .. 2867  =  358 bp
SV40 enhancer and early promoter
SV40 promoter
2510 .. 2867  =  358 bp
SV40 enhancer and early promoter
cer region
5807 .. 6090  =  284 bp
ColE1-derived recombination site that helps to maintain plasmids as monomers
cer region
5807 .. 6090  =  284 bp
ColE1-derived recombination site that helps to maintain plasmids as monomers
CMV promoter
518 .. 721  =  204 bp
human cytomegalovirus (CMV) immediate early promoter
CMV promoter
518 .. 721  =  204 bp
human cytomegalovirus (CMV) immediate early promoter
chimeric intron
857 .. 989  =  133 bp
chimera between introns from human β-globin and immunoglobulin heavy chain genes
chimeric intron
857 .. 989  =  133 bp
chimera between introns from human β-globin and immunoglobulin heavy chain genes
SV40 poly(A) signal
2144 .. 2265  =  122 bp
SV40 polyadenylation signal
SV40 poly(A) signal
2144 .. 2265  =  122 bp
SV40 polyadenylation signal
AmpR promoter
3980 .. 4084  =  105 bp
AmpR promoter
3980 .. 4084  =  105 bp
MCS
1997 .. 2072  =  76 bp
multiple cloning site
MCS
1997 .. 2072  =  76 bp
multiple cloning site
poly(A) signal
3776 .. 3824  =  49 bp
synthetic polyadenylation signal
poly(A) signal
3776 .. 3824  =  49 bp
synthetic polyadenylation signal
T7 promoter
1033 .. 1051  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T7 promoter
1033 .. 1051  =  19 bp
promoter for bacteriophage T7 RNA polymerase
SV40 ori
2718 .. 2853  =  136 bp
SV40 origin of replication
SV40 ori
2718 .. 2853  =  136 bp
SV40 origin of replication
ORF:  1067 .. 2107  =  1041 bp
ORF:  346 amino acids  =  39.0 kDa
ORF:  2918 .. 3712  =  795 bp
ORF:  264 amino acids  =  29.0 kDa
ORF:  4085 .. 4945  =  861 bp
ORF:  286 amino acids  =  31.6 kDa
ORF:  3090 .. 3476  =  387 bp
ORF:  128 amino acids  =  14.6 kDa
ORF:  2034 .. 2282  =  249 bp
ORF:  82 amino acids  =  9.2 kDa
ORF:  3588 .. 3893  =  306 bp
ORF:  101 amino acids  =  11.5 kDa
ORF:  821 .. 1630  =  810 bp
ORF:  269 amino acids  =  29.4 kDa
ORF:  3227 .. 3763  =  537 bp
ORF:  178 amino acids  =  19.8 kDa
ORF:  1630 .. 1866  =  237 bp
ORF:  78 amino acids  =  8.0 kDa
ORF:  4549 .. 4815  =  267 bp
ORF:  88 amino acids  =  9.2 kDa
Click here to try SnapGene

Download pHTN HaloTag CMV-neo.dna file

SnapGene

SnapGene is the easiest way to plan, visualize and document your everyday molecular biology procedures

  • Fast accurate construct design for all major molecular cloning techniques
  • Validate sequenced constructs using powerful alignment tools
  • Customize plasmid maps with flexible annotation and visualization controls
  • Automatically generate a rich graphical history of every edit and procedure

SnapGene Viewer

SnapGene Viewer is free software that allows molecular biologists to create, browse, and share richly annotated sequence files.

  • Gain unparalleled visibility of your plasmids, DNA and protein sequences
  • Annotate features on your plasmids using the curated feature database
  • Store, search, and share your sequences, files and maps

Individual Sequences & Maps

The maps, notes, and annotations in the zip file on this page are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as ’’www.snapgene.com/resources’’. Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Discover the most user-friendly molecular biology experience.